|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 08/16/21
- Zscaler selected by Schmitz Cargobull to secure Cloud-only storage
- 06/10/21
- Zscaler, ServiceNow integrate to offer enterprise cloud data control
- 05/25/21
- Zscaler jumps 8% to $186.65 after Q3 results beat, FY21 guidance raised
- 05/25/21
- Zscaler to acquire Smokescreen , terms undisclosed
- 08/13/21
- Nintendo's 'Zelda: Skyward Sword' best-selling game of July, says NPD
- 07/16/21
- Sony's new 'Ratchet & Clank' best-selling game in June in U.S., says NPD
- 07/16/21
- June video game spending in U.S. grew 5% year-over-year to $4.9B, says NPD
- 07/26/21
- Geoinvesting short on Up Fintech, sees similar headwinds as DiDi faces
- 06/25/21
- TBSPL gets approval-in-principle for Singapore securities trading
- 09/10/21
- Teradata falls -9.6%
- 09/09/21
- Teradata targets more than $1B in Cloud ARR in FY25
- 06/08/21
- Teradata appoints Bramley as Chief Financial Officer, Culhane to step-down
- 05/07/21
- Teradata falls -11.9%
- 09/10/21
- Epic ordered to pay Apple at least $4M in damages plus portion of lost revenue
- 08/13/21
- Video game hardware spending rose 10% y/y in July, says NPD
- 09/09/21
- Sony unveils 'Star Wars: KOTOR' remake, 'Wolverine' games for PS5
- 08/13/21
- Sonos jumps 7% to $40.80 after judge says Google infringes on five patents
- 08/13/21
- ITC judge determines Google infringes on five Sonos patents
- 05/12/21
- Sonos jumps 16% to $36.64 after Q2 results beat estimates, FY21 guidance raised
- 09/09/21
- Ingredion, S&W Seed enter into U.S. stevia pilot production supply agreement
- 09/09/21
- Dave & Buster's jumps about 7% to $37.94 after Q2 earnings beat, Q3 outlook
- 09/09/21
- Dave & Buster's sees Q3 comparable store sales in line with QTD trends
- 06/10/21
- Dave & Buster's jumps 5% to $46.25 after Q1 results, Q2 guidance top estimates
- 04/21/21
- Dave & Buster's announces appointment of Atish Shah to board of directors
- 09/10/21
- Kroger falls -7.7%
- 09/10/21
- Kroger reports Q2 identical sales without fuel down 0.6%
- 09/10/21
- Kroger reports Q2 gross margin 21.4%
- 09/10/21
- KKR to sell Riata Corporate Park for $300M
- 05/17/21
- Univar, Ingredion expand agreement to distribute PureCircle stevia products
- 05/03/21
- Amyris announces pact with Ingredion for exclusive licensing of Reb M sweetener
- 04/01/21
- Ingredion expands ingredient portfolio with acquisition of KaTech
- 09/03/21
- Impel NeuroPharma Inc trading resumes
- 09/03/21
- Impel NeuroPharma announces FDA approval of TRUDHESA
- 09/03/21
- Impel NeuroPharma Inc trading halted, news pending
- 08/19/21
- Impel NeuroPharma CEO buys 20K shares of common stock
- 08/30/21
- Fresenius Medical Care investing additional $25M in Humacyte
- 06/11/21
- Humacyte expands global partnership with Fresenius Medical Care
- 08/16/21
- Appaloosa adds Uber, cuts T-Mobile in Q2
- 08/13/21
- Soros Capital buys Amazon, exits Netflix in Q2
- 07/22/21
- Freeport McMoRan says generating 'very significant' free cash flow
- 07/22/21
- Freeport McMoRan says recent pullback in copper hasn't altered favorable outlook
- $378.85 /
+1.005 (+0.27%) - 09/10/21
- Facebook's WhatsApp to offer encryption on cloud backups
- 09/09/21
- Facebook announces launch of 'Ray-Ban Stories' smart glasses
- 09/01/21
- Facebook launches Facebook Fantasy Games
- 08/30/21
- Facebook asking Instagram users to share birthday for safety
- $844.29 /
-10.12 (-1.18%) - 08/31/21
- AT&T sets goal to help businesses reduce a gigaton of global emissions by 2035
- 08/12/21
- Verizon expands global automation capabilities with Equinix
- 06/22/21
- Nvidia announces AI LaunchPad for infrastructure for enterprises
- 06/16/21
- Equinix sets 2030 global climate-neutral target
- 09/09/21
- Endo settles NY State opioid cases for total payment of $50M
- 08/31/21
- Endo to appeal non-infringement ruling in favor of Eagle Pharmaceuticals
- 08/31/21
- Eagle Pharmaceuticals confirms win in vasopressin patent trial
- 08/31/21
- Eagle Pharmaceuticals up after court says Par failed to prove ANDA will infringe
- 09/08/21
- Editas Medicine appoints Emma Reeve to board of directors
- 08/20/21
- Editas Medicine presents data on SLEEK gene editing technology
- 08/04/21
- Editas Medicine expects cash to fund operating expenses well into 2023
- 07/29/21
- Editas Medicine, IDT announce publication in Nature Communications
- $184.13 /
-1.775 (-0.95%) - 09/06/21
- Fly Intel: Top five weekend stock stories
- 09/08/21
- DigitalBridge to sell Wellness Infrastructure unit in deal valued at $3.2B
- 08/10/21
- DigitalBridge to acquire controlling stake in Vertical Bridge, no terms
- 07/26/21
- DigitalBridge acquires data center business of PCCW
- 07/20/21
- Thomas Barrack charged with acting as agent of foreign government, DOJ says
- 09/07/21
- Tritium annnounces A$40M private placement financing by Cigna Investments
- 09/02/21
- Tenet, Cigna extend and expand network access
- 08/26/21
- Cigna expands, enhances ACA marketplace plans
- 08/24/21
- Cigna announces $2B in accelerated share repurchase agreements
- 08/18/21
- Crown Castle names Catherine Piche as COO for Towers
- 04/12/21
- Verizon announces deals with Crown Castle and SBA Communications
- 03/10/21
- Crown Castle CFO Schlanger sells over $750K in shares
- 08/16/21
- Paulson buys Bally's, cuts Dish Network in Q2
- 08/16/21
- Omega Advisors buys Bausch Health, exits Comcast Class A in Q2
- 08/03/21
- Bausch Health announces intentions to pursue IPO of Solta Medical business
- 07/12/21
- Bausch Health eye business launches lubricant eye drops, eyelid cleansing wipes
- 09/10/21
- Bank of America adding five new members to senior management team
- 08/26/21
- Bank of America announces retirement of Vice Chairman Finucane, COO Montag
- 08/16/21
- Berkshire Hathaway exits Biogen, boosts Kroger in Q2
- 08/16/21
- Bank of America reports July net charge-offs 2.39% vs. 2.53% in prior month
- $34.98 /
-20.67 (-37.14%) - 09/09/21
- Apellis down 32% as phase 3 DERBY study of pegcetacoplan did not meet endpoint
- 09/09/21
- Apellis plans NDA for pegcetacoplan for GA to FDA after studies met endpoint
- 09/09/21
- Apellis Pharmaceuticals trading halted, news pending
- 07/26/21
- Apellis announces closing of previously announced exchanges
AOUT American Outdoor Brands - 07/15/21
- American Outdoor Brands reports Q4 gross margin 44.4%, flat y/y
- 05/04/21
- American Outdoor Brands names Curtis Smith as Chief Marketing Officer
- 03/17/21
- American Outdoor Brands jumps 10% to $25.65 after beat and raise quarter
- 06/16/21
- American Tower partners with Allianz in Europe
- 05/05/21
- CDPQ to acquire 30% stake in ATC Europe
- 03/15/21
- American Tower, Dish in master lease pact for up to 20,000 sites
- 09/10/21
- Albemarle announces FY26 revenue growth target 13%-17%
- 06/01/21
- W.R. Grace completes acquisition of Fine Chemistry business
- 03/31/21
- Piedmont Lithium names David Klanecky as COO
- $123.75 /
+31.65 (+34.36%) - 09/09/21
- Affirm jumps 18% above $109 per share after Q4 results and guidance
- 08/27/21
- Affirm jumps 28% to $86.84 per share after announcing partnership with Amazon
- 08/27/21
- Amazon partners with Affirm to deliver pay-over-time option
- 08/03/21
- Affirm up 4% after Bloomberg says working with Apple on 'BNPL' program in Canada
- 09/10/21
- Apple general counsel calls Epic court ruling 'huge win for Apple'
- 09/10/21
- Epic CEO responds to Apple, says ruling not 'a win for developers or consumers'
- 09/10/21
- Apple says Epic case affirms 'App Store is not in violation of antitrust law'
- 09/10/21
- Judge in Epic lawsuit says Apple 'engaging in anticompetitive conduct'
- 09/10/21 Truist
- Apple will likely appeal ruling in Epic case, says Truist
- 09/10/21 Wedbush
- Wedbush says Apple injunction could boost earnings for mobile game makers
- 09/10/21 Baird
- Apple ruling could be positive for mobile game publishers, says Baird
- 09/10/21 Piper Sandler
- Apple court ruling not likely to materially impact business, says Piper Sandler
- 09/06/21 KGI Securities
- Tencent initiated with an Outperform at KGI Securities
- 08/20/21 Erste Group
- Tencent downgraded to Sell from Hold at Erste Group
- 08/19/21 Mizuho
- Tencent price target lowered to HK$530 from HK$650 at Mizuho
- 08/11/21 Deutsche Bank
- KKR upgraded to Buy on durable earnings power at Deutsche Bank
- 08/11/21 Deutsche Bank
- KKR upgraded to Buy from Hold at Deutsche Bank
- 08/05/21 JMP Securities
- KKR upgraded to Outperform from Market Perform at JMP Securities
- $184.13 /
-1.775 (-0.95%) - 09/09/21 Arete
- Disney initiated with a Buy at Arete
- 08/30/21 JPMorgan
- Movie executives see 10% of screens closing, down from 15%, says JPMorgan
- 08/27/21 Deutsche Bank
- Disney price target lowered to $200 from $213 at Deutsche Bank
- 07/27/21 Morgan Stanley
- Sony upgraded to Overweight at Morgan Stanley on animation business growth
- 07/27/21 Morgan Stanley
- Sony upgraded to Overweight from Equal Weight at Morgan Stanley
- 07/19/21 Odeon Capital
- Bank of America downgraded to Hold from Buy at Odeon Capital
- 07/06/21 Keefe Bruyette
- Bank of America assumed with a Market Perform at Keefe Bruyette
- 06/02/21 Truist
- Bank of America initiated with a Buy at Truist
- 05/04/21
- Fly Intel: Top five analyst downgrades
- $123.75 /
+31.65 (+34.36%) - 09/10/21 BofA
- Affirm price target raised to $119 from $82 at BofA
- 09/10/21 Truist
- Affirm price target raised to $150 from $120 at Truist
- 09/10/21 Morgan Stanley
- Affirm price target raised to $140 from $120 at Morgan Stanley
- 09/10/21 DA Davidson
- Affirm price target raised to $110 from $85 at DA Davidson
- $34.98 /
-20.67 (-37.14%) - 09/10/21 BMO Capital
- Apellis price target lowered to $69 from $89 at BMO Capital
- 09/10/21 Cowen
- Cowen says Apellis data 'could not be more positive' for Iveric, ups target
- 09/10/21 Jefferies
- Jefferies continues to see Apellis' pegcetacoplan as approvable in GA
- 09/10/21 Needham
- Apellis price target lowered to $70 from $85 at Needham
- 09/10/21 Loop Capital
- Zscaler price target raised to $280 from $250 at Loop Capital
- 09/10/21 BMO Capital
- Zscaler price target raised to $315 from $250 at BMO Capital
- 09/10/21 Cowen
- Zscaler price target raised to $314 from $255 at Cowen
- 09/10/21 Truist
- Zscaler price target raised to $325 from $225 at Truist
- 09/10/21
- Fly Intel: Top five analyst downgrades
- 09/10/21 BofA
- Cigna downgraded to Underperform from Buy at BofA
- 09/09/21 Cowen
- Cigna initiated with a Market Perform at Cowen
- 09/08/21 Mizuho
- Selloff in managed care sector overdone, says Mizuho
- 09/10/21 Credit Suisse
- Credit Suisse downgrades Freeport McMoRan to sell on copper price risk
- 09/10/21 Credit Suisse
- Freeport McMoRan downgraded to Underperform from Neutral at Credit Suisse
- 07/23/21 Deutsche Bank
- Freeport McMoRan price target lowered to $47 from $50 at Deutsche Bank
- 09/10/21
- Fly Intel: Top five analyst upgrades
- 09/10/21 Oppenheimer
- Editas Medicine upgraded to Outperform from Perform at Oppenheimer
- 09/09/21 Oppenheimer
- Editas Medicine upgraded to Outperform from Perform at Oppenheimer
- 08/09/21
- Fly Intel: Top five analyst upgrades
- 09/10/21 Barclays
- Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
- 09/10/21 JPMorgan
- Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
- 08/11/21 JPMorgan
- Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
- 08/04/21 Societe Generale
- Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
- 09/10/21 Morgan Stanley
- American Tower price target raised to $316 from $270 at Morgan Stanley
- 09/10/21 Oppenheimer
- American Tower downgraded to Perform from Outperform at Oppenheimer
- 08/12/21 Argus
- American Tower price target raised to $300 from $288 at Argus
- 08/03/21 Raymond James
- American Tower price target raised to $296 from $261 at Raymond James
- 09/10/21 Morgan Stanley
- Crown Castle price target raised to $213 from $204 at Morgan Stanley
- 09/10/21 Oppenheimer
- Crown Castle downgraded to Perform from Outperform at Oppenheimer
- 07/19/21 KeyBanc
- Crown Castle price target raised to $224 from $207 at KeyBanc
- 07/13/21 LightShed Partners
- Crown Castle downgraded to Neutral from Buy at LightShed Partners
- $844.29 /
-10.12 (-1.18%) - 09/10/21 Oppenheimer
- Equinix downgraded to Perform from Outperform at Oppenheimer
- 08/26/21 Citi
- Switch added to 'positive Catalyst Watch list' at Citi
- 07/29/21 Truist
- Equinix price target raised to $925 from $900 at Truist
- 07/29/21 Credit Suisse
- Equinix price target raised to $942 from $907 at Credit Suisse
- 08/04/21 JPMorgan
- Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
- 08/04/21 Barclays
- Bausch Health price target lowered to $31 from $35 at Barclays
- 07/06/21 Spin-Off Research
- Bausch Health initiated with a Buy at Spin-Off Research
- 06/02/21 Roth Capital
- Clearside success with Xipere can derisk pipeline, says Roth Capital
- $378.85 /
+1.005 (+0.27%) - 09/09/21 JPMorgan
- Netflix, Uber added as top U.S. Internet picks at JPMorgan
- 09/09/21 HSBC
- Facebook price target raised to $300 from $275 at HSBC
- 09/01/21
- Fly Intel: Top five analyst downgrades
- 09/01/21 Rosenblatt
- Facebook downgraded to Neutral from Buy at Rosenblatt
- 08/16/21
- Fly Intel: Top five analyst upgrades
- 08/16/21 Jefferies
- Sonos upgraded to Buy from Hold at Jefferies
- 05/25/21 Stifel
- Plexus warning may be signal that supply constraints will worsen, says Stifel
- 05/13/21 Morgan Stanley
- Morgan Stanley bumps Sonos price target to $47 after 'another beat and raise'
- 08/09/21 Raymond James
- Raymond James starts DigitalBridge at Outperform on shift to digital business
- 08/09/21 Raymond James
- DigitalBridge initiated with an Outperform at Raymond James
- 06/23/21 Cowen
- DigitalBridge price target raised to $9.25 from $7.25 at Cowen
- 06/23/21 B. Riley
- DigitalBridge price target raised to $12 from $11 at B. Riley
- 08/31/21 Piper Sandler
- Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
- 08/31/21 Piper Sandler
- Endo downgraded to Neutral from Overweight at Piper Sandler
- 08/31/21 Cantor Fitzgerald
- Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
- 07/12/21 Citi
- Citi remains buyer of Endo, sees opioid risk as manageable
- 07/13/21 Goldman Sachs
- UP Fintech initiated with a Sell at Goldman Sachs
- 03/04/21 CICC
- UP Fintech initiated with an Outperform at CICC
- 02/26/21 Citi
- UP Fintech price target raised to $38.60 from $8.30 at Citi
- 09/03/21 Cowen
- Impel NeuroPharma price target raised to $55 from $35 at Cowen
- 05/18/21 Wedbush
- Wedbush bullish on Impel NeuroPharma, initiates with an Outperform
- 05/18/21 Wedbush
- Impel NeuroPharma initiated with an Outperform at Wedbush
- 05/18/21 Guggenheim
- Impel NeuroPharma initiated with a Buy at Guggenheim
AOUT American Outdoor Brands - 09/10/21 B. Riley
- American Outdoor guidance reiteration being misinterpreted, says B. Riley
- 07/16/21 Lake Street
- American Outdoor Brands price target raised to $40 from $37 at Lake Street
- 07/16/21 B. Riley
- American Outdoor Brands price target raised to $46 from $44 at B. Riley
- 07/02/21 B. Riley
- American Outdoor, Vista Outdoor setups remain attractive, says B. Riley
- 09/08/21
- Fly Intel: Top five analyst upgrades
- 09/08/21 Berenberg
- Albemarle upgraded to Buy from Sell at Berenberg
- 08/30/21 Cowen
- Albemarle price target raised to $260 from $180 at Cowen
- 08/23/21 Loop Capital
- Albemarle price target raised to $253 from $208 at Loop Capital
- 09/07/21 Wells Fargo
- Kroger price target raised to $46 from $39 at Wells Fargo
- 06/22/21 Northcoast
- Kroger price target raised to $46 from $41 at Northcoast
- 06/21/21 Deutsche Bank
- Kroger price target raised to $41 from $36 at Deutsche Bank
- 06/18/21 MKM Partners
- Kroger price target raised to $40 from $35 at MKM Partners
- 09/10/21 BMO Capital
- Dave & Buster's price target raised to $58 from $54 at BMO Capital
- 09/02/21 Wells Fargo
- Dave & Buster's price target lowered to $38 from $45 at Wells Fargo
- 08/30/21
- Fly Intel: Top five analyst downgrades
- 08/30/21 Raymond James
- Raymond James reiterates Strong Buy rating on Dave & Buster's ahead of earnings
- 08/31/21 Jefferies
- China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
- 08/20/21 Benchmark
- Take-Two price target lowered to $200 from $250 at Benchmark
- 09/10/21 JMP Securities
- Teradata price target raised to $78 from $70 at JMP Securities
- 09/08/21 Stifel
- Stifel says Parker-Hannifin's Meggitt bid has 'smoother route' with Teradata out
- 09/02/21
- Fly Intel: Top five analyst initiations
- 09/02/21 Craig-Hallum
- Teradata initiated with a Buy at Craig-Hallum
- 09/10/21 Lake Street
- S&W Seed pact with Ingredion a 'potential needle-mover,' says Lake Street
- 04/16/21 Lake Street
- S&W Seed initiated with a Buy at Lake Street
- 05/05/21 Stephens
- Stephens downgrades Ingredion to Equal Weight on lower beat and raise potential
- 05/05/21 Stephens
- Ingredion downgraded to Equal Weight from Overweight at Stephens
- 09/09/21
- Zscaler sees FY22 EPS 52c-56c, consensus 56c
- 09/09/21
- Zscaler sees Q1 EPS 12c, consensus 12c
- 09/09/21
- Zscaler reports Q4 EPS 14c, consensus 9c
- 09/09/21
- Take-Two backs FY22 EPS view $1.95-$2.20, consensus $4.58
- 08/02/21
- Take-Two backs FY22 EPS view $1.95-$2.20, consensus $4.72
- 08/02/21
- Take-Two sees Q2 EPS 35c-45c, consensus $1.36
- 08/02/21
- Take-Two reports Q1 GAAP EPS $1.30, consensus 89c
- 09/10/21
- UP Fintech reports Q2 EPS 3c, one estimate 9c
- 09/09/21
- Teradata backs FY21 adjusted EPS view $1.92-$1.96, consensus $1.97
- 09/09/21
- Teradata sees FY22 adjusted EPS $1.60-$1.70, consensus $2.04
- 08/05/21
- Teradata raises FY21 adjusted EPS view to $1.92-$1.96, consensus $1.58
- 08/05/21
- Teradata sees Q3 adjusted EPS 30c-34c, consensus 28c
- 08/04/21
- Sony sees FY22 sales Y9.7T, net income Y700B, operating income Y90B
- 08/04/21
- Sony reports Q1 EPS Y170.95 vs. Y158.59 last year
- 04/28/21
- Sony sees FY21 sales JPY9.7T
- 04/28/21
- Sony reports Q4 EPS JPY85.44 vs JPY10.10 last year
- 08/11/21
- Sonos raises FY21 revenue view to $1.695B-$1.71B from $1.625B-$1.675B
- 08/11/21
- Sonos reports Q3 adjusted EPS 27c, consensus (17c)
- 05/12/21
- Sonos raises FY21 revenue view to $1.625B-$1.675B from $1.525B-$1.575B
- 05/12/21
- Sonos raises FY21 revenue view to $1.625B-$1.675B from $1.525B-$1.575B
- 08/19/21
- S&W Seed sees FY21 revenue $84.0M, consensus $94.16M
- 05/13/21
- S&W Seed still sees FY21 total revenue $92.5M-$95.5M, consensus $92.9M
- 05/13/21
- S&W Seed reports Q3 adjusted EPS (7c), consensus (9c)
- 09/09/21
- Dave & Buster's reports Q2 EPS $1.07, consensus 58c
- 06/10/21
- Dave & Buster's sees Q2 revenue $335M-$350M, consensus $287.36M
- 06/10/21
- Dave & Buster's reports Q1 EPS 40c, consensus (16c)
- 06/10/21
- Notable companies reporting after market close
- 09/10/21
- Kroger raises FY21 adjusted EPS view $3.25-$3.35 from $2.95-$3.10
- 09/10/21
- Kroger reports Q2 adjusted EPS 80c, consensus 64c
- 09/09/21
- Notable companies reporting before tomorrow's open
- 08/03/21
- KKR reports Q2 EPS $2.05, consensus 83c
- 08/02/21
- Notable companies reporting before tomorrow's open
- 05/04/21
- KKR reports Q1 after-tax distributable EPS 75c, consensus 63c
- 08/03/21
- Ingredion backs FY21 adjusted EPS view $6.45-$6.85, consensus $6.53
- 08/03/21
- Ingredion reports Q2 adjusted EPS $2.05, consensus $1.55
- 05/04/21
- Ingredion sees Q2 revenue up 20%-30%
- 05/04/21
- Ingredion reports Q1 adjusted EPS $1.85, consensus $1.62
- 08/16/21
- Impel NeuroPharma reports Q2 non=GAAP EPS (79c), two estimates (6c)
- 06/07/21
- Impel NeuroPharma reports Q1 non-GAAP EPS (54c) vs. (54c) last year.
- 04/22/21
- Freeport McMoRan reports Q1 adjusted EPS 51c, consensus 51c
- 04/21/21
- Notable companies reporting before tomorrow's open
- $378.85 /
+1.005 (+0.27%) - 07/28/21
- Facebook says Q3, Q4 revenue growth rates to 'decelerate significantly'
- 07/28/21
- Facebook reports Q2 EPS $3.61, consensus $3.02
- 07/28/21
- Notable companies reporting after market close
- 04/28/21
- Facebook sees Q2 year-over-year revenue growth stable or to modestly accelerate
- $844.29 /
-10.12 (-1.18%) - 07/28/21
- Equinix raises FY21 adjusted FFO to $26.92-$27.36 from $26.72-$27.28
- 07/28/21
- Equinix reports Q2 adjusted FFO $7.01, consensus $6.72
- 04/28/21
- Equinix sees Q2 revenue $1.63B-$1.66B, consensus $1.63B
- 04/28/21
- Equinix narrows FY21 adjusted FFO view to $26.73-$27.28 from $26.72-$27.28
- 08/05/21
- Endo narrows FY21 adjusted EPS to $2.15-$2.30 from $1.95-$2.30
- 08/05/21
- Endo reports Q2 cont-op adjusted EPS 65c, consensus 48c
- 05/06/21
- Endo raises FY21 adjusted EPS view to $1.95-$2.30 from $1.80-$2.30
- 05/06/21
- Endo reports Q1 adjusted cont ops EPS 73c, consensus 48c
- 08/04/21
- Editas Medicine reports Q2 EPS (81c), consensus (83c)
- 05/05/21
- Editas Medicine reports Q1 EPS (86c), consensus (73c)
- $184.13 /
-1.775 (-0.95%) - 08/12/21
- Disney reports Q3 EPS ex-items 80c, consensus 56c
- 08/12/21
- Notable companies reporting after market close
- 05/13/21
- Disney reports Q2 EPS ex-items 79c, consensus 27c
- 05/13/21
- Notable companies reporting after market close
- 08/05/21
- DigitalBridge reports Q2 core FFO (1c), two estimates 4c
- 06/22/21
- DigitalBridge raises FY21 revenue view, introduces longer-term targets
- 08/05/21
- Cigna backs FY21 adjusted EPS view at least $20.20, consensus $20.42
- 08/05/21
- Cigna reports Q2 adjusted EPS $5.24, consensus $4.96
- 08/04/21
- Notable companies reporting before tomorrow's open
- 07/21/21
- Crown Castle raises FY21 AFFO view to $6.78-$6.89 from $6.74-$6.85
- 07/21/21
- Crown Castle reports Q2 AFFO $1.71, consensus $1.66
- 07/21/21
- Notable companies reporting after market close
- 04/21/21
- Crown Castle raises FY21 AFFO view to $6.74-$6.85 from $6.64-$6.74
- 08/03/21
- Bausch Health cuts FY21 revenue view to $8.4B-$8.6B from $8.6B from $8.8B
- 08/03/21
- Bausch Health reports Q2 GAAP EPS ($1.66), consensus 95c
- 05/04/21
- Bausch Health backs FY21 revenue view $8.6B-$8.8B, consensus $8.66B
- 05/04/21
- Bausch Health reports Q1 GAAP EPS ($1.71) vs. (43c) last year
- 07/14/21
- Bank of America reports Q2 EPS $1.03, consensus 77c
- 07/13/21
- Notable companies reporting before tomorrow's open
- 07/13/21
- Fly Intel: What to watch in next round of big bank earnings reports
- $34.98 /
-20.67 (-37.14%) - 08/09/21
- Apellis reports Q2 EPS ($2.72), consensus ($1.70)
- 04/28/21
- Apellis reports Q1 EPS ($2.32), consensus ($1.62)
AOUT American Outdoor Brands - 09/09/21
- American Outdoor Brands sees FY22 non-GAAP EPS $2.02-$2.26, consensus $2.21
- 09/09/21
- American Outdoor Brands reports Q1 non-GAAP EPS 48c, consensus 40c
- 07/15/21
- American Outdoor Brands sees FY22 adjusted EPS view $2.02-$2.26
- 07/15/21
- American Outdoor Brands reports Q4 adjusted EPS 34c, consensus 23c
- 07/29/21
- American Tower raises FY21 midpoint or property revenue, net income
- 07/29/21
- American Tower reports Q2 EPS $1.65, consensus $1.27
- 04/29/21
- American Tower sees FY21 revenue $8.5B-$8.6B, consensus $8.83B
- 04/29/21
- American Tower reports Q1 FFO $2.46, consensus $2.33
- 09/10/21
- Albemarle backs FY21 EPS view $3.35-$3.70, consensus $3.62
- 08/05/21
- Albemarle raises FY21 EPS view to $3.35-3.70 from $3.25-$3.65, consensus $3.61
- 08/04/21
- Albemarle reports Q2 adjusted EPS 89c, consensus 83c
- 05/05/21
- Albemarle backs FY21 adjusted EPS view $3.25-$3.65, consensus $3.50
- $123.75 /
+31.65 (+34.36%) - 09/09/21
- Affirm sees FY22 revenue $1.16B-$1.19B, consensus $1.17B
- 09/09/21
- Affirm sees Q1 revenue $240M-$250M, consensus $233.89M
- 09/09/21
- Affirm reports Q4 EPS (48c), consensus (29c)
- 09/09/21
- Notable companies reporting after market close
- 07/30/21
- Musk sides with Epic, says Apple fees 'de facto global tax' on internet
- 07/27/21
- Apple reports Q3 EPS $1.30, consensus $1.00
- 07/27/21
- Notable companies reporting after market close
- 05/01/21
- Berkshire Hathaway reports Q1 EPS $5.09, consensus $2.53
|
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 08/16/21
- Zscaler selected by Schmitz Cargobull to secure Cloud-only storage
- 06/10/21
- Zscaler, ServiceNow integrate to offer enterprise cloud data control
- 05/25/21
- Zscaler jumps 8% to $186.65 after Q3 results beat, FY21 guidance raised
- 05/25/21
- Zscaler to acquire Smokescreen , terms undisclosed
- 08/13/21
- Nintendo's 'Zelda: Skyward Sword' best-selling game of July, says NPD
- 08/13/21
- Video game hardware spending rose 10% y/y in July, says NPD
- 07/16/21
- Sony's new 'Ratchet & Clank' best-selling game in June in U.S., says NPD
- 07/16/21
- June video game spending in U.S. grew 5% year-over-year to $4.9B, says NPD
- 09/09/21
- Tesla CEO Musk says FSD 10 'will blow your mind'
- 09/07/21
- Ford hires Apple's Field as Chief Advanced Technology, Embedded Systems Officer
- 09/07/21
- Tesla CEO says Full Self-Driving Beta 10 goes out 'a week from Friday'
- 09/01/21
- Tesla CEO says Roadster 'should ship' in 2023
- 07/26/21
- Geoinvesting short on Up Fintech, sees similar headwinds as DiDi faces
- 06/25/21
- TBSPL gets approval-in-principle for Singapore securities trading
- 09/10/21
- Teradata falls -9.6%
- 09/09/21
- Teradata targets more than $1B in Cloud ARR in FY25
- 06/08/21
- Teradata appoints Bramley as Chief Financial Officer, Culhane to step-down
- 05/07/21
- Teradata falls -11.9%
- 08/01/21
- Fly Intel: Top five weekend stock stories
- 09/10/21
- Zynga, Roblox, Match Group, Spotify rally after Apple-Epic court ruling
- 08/31/21
- Spotify rolls out Blend personalized experience
- 08/24/21
- Spotify making Podcast Subscriptions available to all U.S. podcasters
- 08/20/21
- Spotify announces stock repurchase program up to $1B
- 09/09/21
- Sony unveils 'Star Wars: KOTOR' remake, 'Wolverine' games for PS5
- 09/08/21
- Sony's PlayStation Studios acquires Firesprite, terms not disclosed
- 09/09/21
- Ingredion, S&W Seed enter into U.S. stevia pilot production supply agreement
- 09/10/21
- Porch Group to acquire CSE Insurance, American Home Protect
- 08/17/21
- Porch.com reports acquisition of Rynoh during Q2
- 06/22/21
- Porch.com to join Russell 2000 Index
- 06/08/21
- Homeowners of America introduces services in Illinois
- 09/10/21
- Kroger falls -7.7%
- 09/10/21
- Kroger reports Q2 identical sales without fuel down 0.6%
- 09/10/21
- Kroger reports Q2 gross margin 21.4%
- 09/10/21
- KKR to sell Riata Corporate Park for $300M
- 09/09/21
- KKR to invest $40M in Jet Edge
- 05/17/21
- Univar, Ingredion expand agreement to distribute PureCircle stevia products
- 05/03/21
- Amyris announces pact with Ingredion for exclusive licensing of Reb M sweetener
- 04/01/21
- Ingredion expands ingredient portfolio with acquisition of KaTech
- 09/03/21
- Impel NeuroPharma Inc trading resumes
- 09/03/21
- Impel NeuroPharma announces FDA approval of TRUDHESA
- 09/03/21
- Impel NeuroPharma Inc trading halted, news pending
- 08/19/21
- Impel NeuroPharma CEO buys 20K shares of common stock
- 08/30/21
- Fresenius Medical Care investing additional $25M in Humacyte
- 06/11/21
- Humacyte expands global partnership with Fresenius Medical Care
- 08/16/21
- Appaloosa adds Uber, cuts T-Mobile in Q2
- 08/13/21
- Soros Capital buys Amazon, exits Netflix in Q2
- 07/22/21
- Freeport McMoRan says generating 'very significant' free cash flow
- 07/22/21
- Freeport McMoRan says recent pullback in copper hasn't altered favorable outlook
- $381.22 /
+3.375 (+0.89%) - 09/10/21
- Facebook's WhatsApp to offer encryption on cloud backups
- 09/09/21
- Facebook announces launch of 'Ray-Ban Stories' smart glasses
- 09/01/21
- Facebook launches Facebook Fantasy Games
- 08/30/21
- Facebook asking Instagram users to share birthday for safety
- 08/31/21
- AT&T sets goal to help businesses reduce a gigaton of global emissions by 2035
- 08/12/21
- Verizon expands global automation capabilities with Equinix
- 06/22/21
- Nvidia announces AI LaunchPad for infrastructure for enterprises
- 06/16/21
- Equinix sets 2030 global climate-neutral target
- 09/09/21
- Endo settles NY State opioid cases for total payment of $50M
- 08/31/21
- Endo to appeal non-infringement ruling in favor of Eagle Pharmaceuticals
- 08/31/21
- Eagle Pharmaceuticals confirms win in vasopressin patent trial
- 08/31/21
- Eagle Pharmaceuticals up after court says Par failed to prove ANDA will infringe
- 09/08/21
- Editas Medicine appoints Emma Reeve to board of directors
- 08/20/21
- Editas Medicine presents data on SLEEK gene editing technology
- 08/04/21
- Editas Medicine expects cash to fund operating expenses well into 2023
- 07/29/21
- Editas Medicine, IDT announce publication in Nature Communications
- 09/06/21
- Fly Intel: Top five weekend stock stories
- 08/27/21
- Disney jumps 2% to $179.51 after WSJ report of ESPN sports-betting talks
- 09/07/21
- Tritium annnounces A$40M private placement financing by Cigna Investments
- 09/02/21
- Tenet, Cigna extend and expand network access
- 08/26/21
- Cigna expands, enhances ACA marketplace plans
- 08/24/21
- Cigna announces $2B in accelerated share repurchase agreements
- 08/18/21
- Crown Castle names Catherine Piche as COO for Towers
- 04/12/21
- Verizon announces deals with Crown Castle and SBA Communications
- 03/10/21
- Crown Castle CFO Schlanger sells over $750K in shares
- 08/16/21
- Paulson buys Bally's, cuts Dish Network in Q2
- 08/16/21
- Omega Advisors buys Bausch Health, exits Comcast Class A in Q2
- 08/03/21
- Bausch Health announces intentions to pursue IPO of Solta Medical business
- 07/12/21
- Bausch Health eye business launches lubricant eye drops, eyelid cleansing wipes
- 09/10/21
- Bank of America adding five new members to senior management team
- 08/26/21
- Bank of America announces retirement of Vice Chairman Finucane, COO Montag
- 08/16/21
- Berkshire Hathaway exits Biogen, boosts Kroger in Q2
- 08/16/21
- Bank of America reports July net charge-offs 2.39% vs. 2.53% in prior month
- $31.02 /
-24.63 (-44.26%) - 09/09/21
- Apellis down 32% as phase 3 DERBY study of pegcetacoplan did not meet endpoint
- 09/09/21
- Apellis plans NDA for pegcetacoplan for GA to FDA after studies met endpoint
- 09/09/21
- Apellis Pharmaceuticals trading halted, news pending
- 07/26/21
- Apellis announces closing of previously announced exchanges
AOUT American Outdoor Brands - 07/15/21
- American Outdoor Brands reports Q4 gross margin 44.4%, flat y/y
- 05/04/21
- American Outdoor Brands names Curtis Smith as Chief Marketing Officer
- 03/17/21
- American Outdoor Brands jumps 10% to $25.65 after beat and raise quarter
- 06/16/21
- American Tower partners with Allianz in Europe
- 05/05/21
- CDPQ to acquire 30% stake in ATC Europe
- 03/15/21
- American Tower, Dish in master lease pact for up to 20,000 sites
- 09/10/21
- Albemarle announces FY26 revenue growth target 13%-17%
- 06/01/21
- W.R. Grace completes acquisition of Fine Chemistry business
- 03/31/21
- Piedmont Lithium names David Klanecky as COO
- $121.63 /
+29.53 (+32.06%) - 09/09/21
- Affirm jumps 18% above $109 per share after Q4 results and guidance
- 08/27/21
- Affirm jumps 28% to $86.84 per share after announcing partnership with Amazon
- 08/27/21
- Amazon partners with Affirm to deliver pay-over-time option
- 08/03/21
- Affirm up 4% after Bloomberg says working with Apple on 'BNPL' program in Canada
- 09/10/21
- Apple says Epic case affirms 'App Store is not in violation of antitrust law'
- 09/10/21
- Judge in Epic lawsuit says Apple 'engaging in anticompetitive conduct'
- 09/10/21
- Epic ordered to pay Apple at least $4M in damages plus portion of lost revenue
- 09/10/21
- Apple down 2% after U.S. judge issues ruling in Epic antitrust case
- 09/10/21
- Apple has resolved Watch 7 quality issues, TFI's Ming-Chi Kuo says
- 09/09/21 Piper Sandler
- Apple price target raised to $175 from $165 at Piper Sandler
- 09/08/21 Baird
- Apple price target raised to $170 from $160 at Baird
- 09/08/21 Morgan Stanley
- App Store headlines 'more bark than bite' for Apple, says Morgan Stanley
- 07/19/21 Odeon Capital
- Bank of America downgraded to Hold from Buy at Odeon Capital
- 07/06/21 Keefe Bruyette
- Bank of America assumed with a Market Perform at Keefe Bruyette
- 06/02/21 Truist
- Bank of America initiated with a Buy at Truist
- 05/04/21
- Fly Intel: Top five analyst downgrades
- $121.63 /
+29.53 (+32.06%) - 09/10/21 BofA
- Affirm price target raised to $119 from $82 at BofA
- 09/10/21 Truist
- Affirm price target raised to $150 from $120 at Truist
- 09/10/21 Morgan Stanley
- Affirm price target raised to $140 from $120 at Morgan Stanley
- 09/10/21 DA Davidson
- Affirm price target raised to $110 from $85 at DA Davidson
- $31.02 /
-24.63 (-44.26%) - 09/10/21 BMO Capital
- Apellis price target lowered to $69 from $89 at BMO Capital
- 09/10/21 Cowen
- Cowen says Apellis data 'could not be more positive' for Iveric, ups target
- 09/10/21 Jefferies
- Jefferies continues to see Apellis' pegcetacoplan as approvable in GA
- 09/10/21 Needham
- Apellis price target lowered to $70 from $85 at Needham
- 09/10/21 Loop Capital
- Zscaler price target raised to $280 from $250 at Loop Capital
- 09/10/21 BMO Capital
- Zscaler price target raised to $315 from $250 at BMO Capital
- 09/10/21 Cowen
- Zscaler price target raised to $314 from $255 at Cowen
- 09/10/21 Truist
- Zscaler price target raised to $325 from $225 at Truist
- 08/04/21 JPMorgan
- Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
- 08/04/21 Barclays
- Bausch Health price target lowered to $31 from $35 at Barclays
- 07/06/21 Spin-Off Research
- Bausch Health initiated with a Buy at Spin-Off Research
- 06/02/21 Roth Capital
- Clearside success with Xipere can derisk pipeline, says Roth Capital
- $381.22 /
+3.375 (+0.89%) - 09/09/21 JPMorgan
- Netflix, Uber added as top U.S. Internet picks at JPMorgan
- 09/09/21 HSBC
- Facebook price target raised to $300 from $275 at HSBC
- 09/01/21
- Fly Intel: Top five analyst downgrades
- 09/01/21 Rosenblatt
- Facebook downgraded to Neutral from Buy at Rosenblatt
- 09/10/21 Craig-Hallum
- VIA Optronics price target lowered to $14 from $18 at Craig-Hallum
- 09/10/21 Piper Sandler
- Aspen Aerogels initiated with Overweight, $58 target at Piper Sandler
- 09/08/21 GLJ Research
- Tesla sales in China in August a 'big problem,' says GLJ Research
- 08/31/21 Bernstein
- Apple car likely all-electric, not expected before 2025, says Bernstein
- 09/07/21
- Fly Intel: Top five analyst upgrades
- 09/07/21 KeyBanc
- Spotify upgraded to Overweight on favorable dynamics at KeyBanc
- 09/07/21 KeyBanc
- Spotify upgraded to Overweight from Sector Weight at KeyBanc
- 07/30/21 Truist
- Spotify price target lowered to $270 from $290 at Truist
- 08/31/21 Piper Sandler
- Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
- 08/31/21 Piper Sandler
- Endo downgraded to Neutral from Overweight at Piper Sandler
- 08/31/21 Cantor Fitzgerald
- Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
- 07/12/21 Citi
- Citi remains buyer of Endo, sees opioid risk as manageable
- 09/10/21 Lake Street
- S&W Seed pact with Ingredion a 'potential needle-mover,' says Lake Street
- 04/16/21 Lake Street
- S&W Seed initiated with a Buy at Lake Street
- 05/05/21 Stephens
- Stephens downgrades Ingredion to Equal Weight on lower beat and raise potential
- 05/05/21 Stephens
- Ingredion downgraded to Equal Weight from Overweight at Stephens
- 07/13/21 Goldman Sachs
- UP Fintech initiated with a Sell at Goldman Sachs
- 03/04/21 CICC
- UP Fintech initiated with an Outperform at CICC
- 02/26/21 Citi
- UP Fintech price target raised to $38.60 from $8.30 at Citi
- 09/03/21 Cowen
- Impel NeuroPharma price target raised to $55 from $35 at Cowen
- 05/18/21 Wedbush
- Wedbush bullish on Impel NeuroPharma, initiates with an Outperform
- 05/18/21 Wedbush
- Impel NeuroPharma initiated with an Outperform at Wedbush
- 05/18/21 Guggenheim
- Impel NeuroPharma initiated with a Buy at Guggenheim
AOUT American Outdoor Brands - 09/10/21 B. Riley
- American Outdoor guidance reiteration being misinterpreted, says B. Riley
- 07/16/21 Lake Street
- American Outdoor Brands price target raised to $40 from $37 at Lake Street
- 07/16/21 B. Riley
- American Outdoor Brands price target raised to $46 from $44 at B. Riley
- 07/02/21 B. Riley
- American Outdoor, Vista Outdoor setups remain attractive, says B. Riley
- 09/08/21
- Fly Intel: Top five analyst upgrades
- 09/08/21 Berenberg
- Albemarle upgraded to Buy from Sell at Berenberg
- 08/30/21 Cowen
- Albemarle price target raised to $260 from $180 at Cowen
- 08/23/21 Loop Capital
- Albemarle price target raised to $253 from $208 at Loop Capital
- 09/07/21 Wells Fargo
- Kroger price target raised to $46 from $39 at Wells Fargo
- 06/22/21 Northcoast
- Kroger price target raised to $46 from $41 at Northcoast
- 06/21/21 Deutsche Bank
- Kroger price target raised to $41 from $36 at Deutsche Bank
- 06/18/21 MKM Partners
- Kroger price target raised to $40 from $35 at MKM Partners
- 09/10/21 Benchmark
- Porch Group price target raised to $30 from $26 at Benchmark
- 09/10/21 Stephens
- Porch Group acquisitions 'two more smart deals,' says Stephens
- 08/17/21 Benchmark
- Porch.com likely not done raising guidance, says Benchmark
- 06/28/21 Oppenheimer
- Porch.com initiated with an Outperform at Oppenheimer
- 08/31/21 Jefferies
- China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
- 08/20/21 Benchmark
- Take-Two price target lowered to $200 from $250 at Benchmark
- 08/16/21 Truist
- Take-Two price target lowered to $200 from $220 at Truist
- 08/03/21 MKM Partners
- Take-Two price target lowered to $180 from $185 at MKM Partners
- 09/10/21 JMP Securities
- Teradata price target raised to $78 from $70 at JMP Securities
- 09/08/21 Stifel
- Stifel says Parker-Hannifin's Meggitt bid has 'smoother route' with Teradata out
- 09/02/21
- Fly Intel: Top five analyst initiations
- 09/02/21 Craig-Hallum
- Teradata initiated with a Buy at Craig-Hallum
- 09/06/21 KGI Securities
- Tencent initiated with an Outperform at KGI Securities
- 08/20/21 Erste Group
- Tencent downgraded to Sell from Hold at Erste Group
- 08/19/21 Mizuho
- Tencent price target lowered to HK$530 from HK$650 at Mizuho
- 08/05/21 Goldman Sachs
- Tencent upgraded to Conviction Buy from Buy at Goldman Sachs
- 08/11/21 Deutsche Bank
- KKR upgraded to Buy on durable earnings power at Deutsche Bank
- 08/11/21 Deutsche Bank
- KKR upgraded to Buy from Hold at Deutsche Bank
- 08/05/21 JMP Securities
- KKR upgraded to Outperform from Market Perform at JMP Securities
- 08/04/21 Oppenheimer
- KKR price target raised to $72 from $65 at Oppenheimer
- 09/09/21 Arete
- Disney initiated with a Buy at Arete
- 08/30/21 JPMorgan
- Movie executives see 10% of screens closing, down from 15%, says JPMorgan
- 08/27/21 Deutsche Bank
- Disney price target lowered to $200 from $213 at Deutsche Bank
- 08/16/21 Argus
- Disney's TV, theme park, DTC businesses to gain further momentum, Argus says
- 07/27/21 Morgan Stanley
- Sony upgraded to Overweight at Morgan Stanley on animation business growth
- 07/27/21 Morgan Stanley
- Sony upgraded to Overweight from Equal Weight at Morgan Stanley
- 09/10/21
- Fly Intel: Top five analyst downgrades
- 09/10/21 BofA
- Cigna downgraded to Underperform from Buy at BofA
- 09/09/21 Cowen
- Cigna initiated with a Market Perform at Cowen
- 09/08/21 Mizuho
- Selloff in managed care sector overdone, says Mizuho
- 09/10/21 Credit Suisse
- Credit Suisse downgrades Freeport McMoRan to sell on copper price risk
- 09/10/21 Credit Suisse
- Freeport McMoRan downgraded to Underperform from Neutral at Credit Suisse
- 07/23/21 Deutsche Bank
- Freeport McMoRan price target lowered to $47 from $50 at Deutsche Bank
- 09/10/21
- Fly Intel: Top five analyst upgrades
- 09/10/21 Oppenheimer
- Editas Medicine upgraded to Outperform from Perform at Oppenheimer
- 09/09/21 Oppenheimer
- Editas Medicine upgraded to Outperform from Perform at Oppenheimer
- 08/09/21
- Fly Intel: Top five analyst upgrades
- 09/10/21 Barclays
- Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
- 09/10/21 JPMorgan
- Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
- 08/11/21 JPMorgan
- Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
- 08/04/21 Societe Generale
- Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
- 09/10/21 Morgan Stanley
- American Tower price target raised to $316 from $270 at Morgan Stanley
- 09/10/21 Oppenheimer
- American Tower downgraded to Perform from Outperform at Oppenheimer
- 08/12/21 Argus
- American Tower price target raised to $300 from $288 at Argus
- 08/03/21 Raymond James
- American Tower price target raised to $296 from $261 at Raymond James
- 09/10/21 Morgan Stanley
- Crown Castle price target raised to $213 from $204 at Morgan Stanley
- 09/10/21 Oppenheimer
- Crown Castle downgraded to Perform from Outperform at Oppenheimer
- 07/19/21 KeyBanc
- Crown Castle price target raised to $224 from $207 at KeyBanc
- 07/13/21 LightShed Partners
- Crown Castle downgraded to Neutral from Buy at LightShed Partners
- 09/10/21 Oppenheimer
- Equinix downgraded to Perform from Outperform at Oppenheimer
- 08/26/21 Citi
- Switch added to 'positive Catalyst Watch list' at Citi
- 07/29/21 Truist
- Equinix price target raised to $925 from $900 at Truist
- 07/29/21 Credit Suisse
- Equinix price target raised to $942 from $907 at Credit Suisse
- 09/09/21
- Zscaler sees FY22 EPS 52c-56c, consensus 56c
- 09/09/21
- Zscaler sees Q1 EPS 12c, consensus 12c
- 09/09/21
- Zscaler reports Q4 EPS 14c, consensus 9c
- 09/09/21
- Take-Two backs FY22 EPS view $1.95-$2.20, consensus $4.58
- 08/02/21
- Take-Two backs FY22 EPS view $1.95-$2.20, consensus $4.72
- 08/02/21
- Take-Two sees Q2 EPS 35c-45c, consensus $1.36
- 08/02/21
- Take-Two reports Q1 GAAP EPS $1.30, consensus 89c
- 07/26/21
- Tesla reports Q2 non-GAAP EPS $1.45, consensus 96c
- 07/26/21
- Notable companies reporting after market close
- 04/26/21
- Tesla reports Q1 non-GAAP EPS 93c, consensus 79c
- 09/10/21
- UP Fintech reports Q2 EPS 3c, one estimate 9c
- 09/09/21
- Teradata backs FY21 adjusted EPS view $1.92-$1.96, consensus $1.97
- 09/09/21
- Teradata sees FY22 adjusted EPS $1.60-$1.70, consensus $2.04
- 08/05/21
- Teradata raises FY21 adjusted EPS view to $1.92-$1.96, consensus $1.58
- 08/05/21
- Teradata sees Q3 adjusted EPS 30c-34c, consensus 28c
- 07/28/21
- Spotify sees Q4 total revenue EUR2.48B-EUR2.68B
- 07/28/21
- Spotify sees Q3 revenue EUR2.31B-EUR2.51B
- 07/28/21
- Spotify reports Q2 EPS (EUR0.19) vs. (EUR1.91) last year
- 04/28/21
- Spotify sees FY21 revenue EUR9.11B-EUR9.51B
- 08/04/21
- Sony sees FY22 sales Y9.7T, net income Y700B, operating income Y90B
- 08/04/21
- Sony reports Q1 EPS Y170.95 vs. Y158.59 last year
- 04/28/21
- Sony sees FY21 sales JPY9.7T
- 04/28/21
- Sony reports Q4 EPS JPY85.44 vs JPY10.10 last year
- 08/19/21
- S&W Seed sees FY21 revenue $84.0M, consensus $94.16M
- 05/13/21
- S&W Seed still sees FY21 total revenue $92.5M-$95.5M, consensus $92.9M
- 05/13/21
- S&W Seed reports Q3 adjusted EPS (7c), consensus (9c)
- 09/10/21
- Porch Group raises FY21 revenue outlook to $187.5M from $184M, consensus $185.2M
- 08/17/21
- Porch.com raises FY21 revenue view to $184M from $178M, consensus $178.3M
- 08/17/21
- Porch.com reports Q2 EPS (17c), consensus (16c)
- 05/17/21
- Porch.com sees FY21 revenue $175M-$178M, consensus $174.36M
- 09/10/21
- Kroger raises FY21 adjusted EPS view $3.25-$3.35 from $2.95-$3.10
- 09/10/21
- Kroger reports Q2 adjusted EPS 80c, consensus 64c
- 09/09/21
- Notable companies reporting before tomorrow's open
- 08/03/21
- KKR reports Q2 EPS $2.05, consensus 83c
- 08/02/21
- Notable companies reporting before tomorrow's open
- 05/04/21
- KKR reports Q1 after-tax distributable EPS 75c, consensus 63c
- 08/03/21
- Ingredion backs FY21 adjusted EPS view $6.45-$6.85, consensus $6.53
- 08/03/21
- Ingredion reports Q2 adjusted EPS $2.05, consensus $1.55
- 05/04/21
- Ingredion sees Q2 revenue up 20%-30%
- 05/04/21
- Ingredion reports Q1 adjusted EPS $1.85, consensus $1.62
- 08/16/21
- Impel NeuroPharma reports Q2 non=GAAP EPS (79c), two estimates (6c)
- 06/07/21
- Impel NeuroPharma reports Q1 non-GAAP EPS (54c) vs. (54c) last year.
- 04/22/21
- Freeport McMoRan reports Q1 adjusted EPS 51c, consensus 51c
- 04/21/21
- Notable companies reporting before tomorrow's open
- $381.22 /
+3.375 (+0.89%) - 07/28/21
- Facebook says Q3, Q4 revenue growth rates to 'decelerate significantly'
- 07/28/21
- Facebook reports Q2 EPS $3.61, consensus $3.02
- 07/28/21
- Notable companies reporting after market close
- 04/28/21
- Facebook sees Q2 year-over-year revenue growth stable or to modestly accelerate
- 07/28/21
- Equinix raises FY21 adjusted FFO to $26.92-$27.36 from $26.72-$27.28
- 07/28/21
- Equinix reports Q2 adjusted FFO $7.01, consensus $6.72
- 04/28/21
- Equinix sees Q2 revenue $1.63B-$1.66B, consensus $1.63B
- 04/28/21
- Equinix narrows FY21 adjusted FFO view to $26.73-$27.28 from $26.72-$27.28
- 08/05/21
- Endo narrows FY21 adjusted EPS to $2.15-$2.30 from $1.95-$2.30
- 08/05/21
- Endo reports Q2 cont-op adjusted EPS 65c, consensus 48c
- 05/06/21
- Endo raises FY21 adjusted EPS view to $1.95-$2.30 from $1.80-$2.30
- 05/06/21
- Endo reports Q1 adjusted cont ops EPS 73c, consensus 48c
- 08/04/21
- Editas Medicine reports Q2 EPS (81c), consensus (83c)
- 05/05/21
- Editas Medicine reports Q1 EPS (86c), consensus (73c)
- 08/12/21
- Disney reports Q3 EPS ex-items 80c, consensus 56c
- 08/12/21
- Notable companies reporting after market close
- 05/13/21
- Disney reports Q2 EPS ex-items 79c, consensus 27c
- 05/13/21
- Notable companies reporting after market close
- 08/05/21
- Cigna backs FY21 adjusted EPS view at least $20.20, consensus $20.42
- 08/05/21
- Cigna reports Q2 adjusted EPS $5.24, consensus $4.96
- 08/04/21
- Notable companies reporting before tomorrow's open
- 07/21/21
- Crown Castle raises FY21 AFFO view to $6.78-$6.89 from $6.74-$6.85
- 07/21/21
- Crown Castle reports Q2 AFFO $1.71, consensus $1.66
- 07/21/21
- Notable companies reporting after market close
- 04/21/21
- Crown Castle raises FY21 AFFO view to $6.74-$6.85 from $6.64-$6.74
- 08/03/21
- Bausch Health cuts FY21 revenue view to $8.4B-$8.6B from $8.6B from $8.8B
- 08/03/21
- Bausch Health reports Q2 GAAP EPS ($1.66), consensus 95c
- 05/04/21
- Bausch Health backs FY21 revenue view $8.6B-$8.8B, consensus $8.66B
- 05/04/21
- Bausch Health reports Q1 GAAP EPS ($1.71) vs. (43c) last year
- 07/14/21
- Bank of America reports Q2 EPS $1.03, consensus 77c
- 07/13/21
- Notable companies reporting before tomorrow's open
- 07/13/21
- Fly Intel: What to watch in next round of big bank earnings reports
- $31.02 /
-24.63 (-44.26%) - 08/09/21
- Apellis reports Q2 EPS ($2.72), consensus ($1.70)
- 04/28/21
- Apellis reports Q1 EPS ($2.32), consensus ($1.62)
AOUT American Outdoor Brands - 09/09/21
- American Outdoor Brands sees FY22 non-GAAP EPS $2.02-$2.26, consensus $2.21
- 09/09/21
- American Outdoor Brands reports Q1 non-GAAP EPS 48c, consensus 40c
- 07/15/21
- American Outdoor Brands sees FY22 adjusted EPS view $2.02-$2.26
- 07/15/21
- American Outdoor Brands reports Q4 adjusted EPS 34c, consensus 23c
- 07/29/21
- American Tower raises FY21 midpoint or property revenue, net income
- 07/29/21
- American Tower reports Q2 EPS $1.65, consensus $1.27
- 04/29/21
- American Tower sees FY21 revenue $8.5B-$8.6B, consensus $8.83B
- 04/29/21
- American Tower reports Q1 FFO $2.46, consensus $2.33
- 09/10/21
- Albemarle backs FY21 EPS view $3.35-$3.70, consensus $3.62
- 08/05/21
- Albemarle raises FY21 EPS view to $3.35-3.70 from $3.25-$3.65, consensus $3.61
- 08/04/21
- Albemarle reports Q2 adjusted EPS 89c, consensus 83c
- 05/05/21
- Albemarle backs FY21 adjusted EPS view $3.25-$3.65, consensus $3.50
- $121.63 /
+29.53 (+32.06%) - 09/09/21
- Affirm sees FY22 revenue $1.16B-$1.19B, consensus $1.17B
- 09/09/21
- Affirm sees Q1 revenue $240M-$250M, consensus $233.89M
- 09/09/21
- Affirm reports Q4 EPS (48c), consensus (29c)
- 09/09/21
- Notable companies reporting after market close
- 07/30/21
- Musk sides with Epic, says Apple fees 'de facto global tax' on internet
- 07/27/21
- Apple reports Q3 EPS $1.30, consensus $1.00
- 07/27/21
- Notable companies reporting after market close
- 05/01/21
- Berkshire Hathaway reports Q1 EPS $5.09, consensus $2.53
|